Curious If Prolistem is Right For Your Azoospermia?

Prolistem® - Supportive Treatment For Azoospermia (Zero Sperm Count)

Prolistem® is a fertility support solution that can significantly enhance the chances of sperm production for men with non-obstructive azoospermia (primary testicular failure). Prolistem® is Formulated by experts, patented and FDA-certified.

Prolistem® does it like rebooting your smartphone to fix glitches. Our six-month program has two steps: first, we create the perfect setting for sperm production by temporarily lowering testosterone. Then, in phase two, we bring testosterone back to normal, promoting robust and healthy sperm production. It’s like hitting a refresh button for your fertility journey!

The outcome of research about non-obstructive azoospermia,
Testosterone and Spermatogonial Stem Cell

Find more about Prolistem new strategy, different levels of treatment, mechanism and ingredients
Read about real people (with maturation arrest or Sertoli cell- only syndrome) with real stories on their use of our treatment


Dr. Abuelhija is a well-respected member of the scientific community who has been working in reproductive research since 2004. During this time, he has obtained a BSc, MSc, and Ph.D., and has published many scientific papers about his findings. Dr. Abuelhija has collaborated with some of the best scientific minds to ensure Prolistem® is one of the best fertility supplements on the market, helping men with azoospermia have children.


Prolistem® Clinical Approved by the Turkish Urology Association

Prolistem® Clinical Approved by the Turkish Urology Association

The Prolistem treatment has emerged as a breakthrough for men grappling with non-obstructive azoospermia, a condition that can be incredibly…

Introducing Prolistem® at the ESHRE Conference

Introducing Prolistem® at the ESHRE Conference

We are proud to be a part of the exciting ESHRE 2023 conference, where new technologies and treatments are being…

Prolistem® approved by JFDA

Prolistem® approved by JFDA

We are thrilled to announce that Prolistem®, developed by Medhija LLC, has received approval from the Jordan Food and Drug…


Get in touch and let us know how we can help